PLA2G6 and Parkinson disease: Notably, 15 of these targets, including PINK1, PARK7, VPS35, FBXO7, SYNJ1, PLA2G6, and TOR1A were previously annotated as PD-associated genes in the GWAS Catalog [13], ClinGen [12], or Open Target [14], supporting the validity of our prioritization strategy.